Amneal Pharmaceuticals, Inc.

American publicly traded generics and specialty pharmaceutical company

AMRX NYSE ISIN US03168L1052 SEC CIK 1723128 LEI 549300VV176ZO5WQHZ61
Follow Amneal Pharmaceuticals Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $862.7M +10% vs same quarter last year
Net income −$21.7M −1015.8% vs same quarter last year
EPS, diluted −$0.06 −700% vs same quarter last year
Operating cash flow $98.3M −17% vs same quarter last year
Revenue by quarter
$730.5M
$695.4M
$724.5M
$784.5M
$814.3M
$722.5M
$796.2M
$862.7M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income10 fiscal years
  • Revenue
  • Net income
−$1B$0$1B$2B$3B$4BFY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$3B$72.1M
FY24$2.8B−$116.9M
FY23$2.4B−$84M
FY22$2.2B−$270.6M
FY21$2.1B$13.2M
FY20$2B$67.8M
FY19$1.6B−$603.6M
FY18$1.7B−$19.7M
FY17$1B$0
FY16$1B$0
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−50%−25%0%25%50%75%FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2536.9%13.1%2.4%
FY2436.5%8.9%−4.2%
FY2334.3%8.5%−3.5%
FY2235.5%−4.3%−12.2%
FY2136.7%7.3%0.6%
FY2031.5%4.6%3.4%
FY1921.7%−15.3%−37.1%
FY1843.1%−1.2%−1.2%
FY1750.9%23.7%0%
FY1658.7%28%0%
Free cash flowOperating cash flow minus capital expenditure
−$100M$0$100M$200M$300M$400MFY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$269.9M
FY24$243.2M
FY23$302.4M
FY22$18.7M
FY21$194.1M
FY20$322.6M
FY19−$45.5M
FY18$167.1M
FY17$139.4M
FY16−$7.7M
Returned to shareholdersDividends paid and shares bought back
$0$100M$200M$300M$400MFY17FY19FY21FY23FY25
Show the numbers
YearDividends
FY25-
FY24-
FY23-
FY22-
FY21-
FY20$0
FY19$0
FY18$183M
FY17$375.3M
FY16$200.6M
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Amneal Pharmaceuticals
  • Healthcare median
−100%−75%−50%−25%0%25%FY17FY19FY21FY23FY25
Show the numbers
YearAmneal PharmaceuticalsHealthcare median
FY252.4%−30.6%
FY24−4.2%−47%
FY23−3.5%−58%
FY22−12.2%−80.4%
FY210.6%−71.9%
FY203.4%−62.2%
FY19−37.1%−46.3%
FY18−1.2%−49.6%
FY170%−45.9%
FY160%−36%